Drugs in Dev.
Pulmonary/Respiratory Diseases
Phase II/ Phase III
Israel 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Human, Alpha-1 Antitrypsin
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Human, Alpha-1 Antitrypsin is a drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Emphysema.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 08, 2010
Lead Product(s) : Human, Alpha-1 Antitrypsin
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Phase II/ Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
